TDOC - CIK 0001477449
Teladoc Health, Inc. trades as TDOC and has a market capitalization of $1.27 B, making it the #2459 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $2.53B, down 1.5% from the prior year and net income of -$200.32M. This page tracks Teladoc Health, Inc. through 1,535 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 10 fiscal years Teladoc Health, Inc.'s revenue grew from $77.38M to $2.53B, a compound annual growth rate of 41.7%. Net profit margin expanded from -60.3% to -7.9% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| SD | - | 2026-05-26 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Major company event | 8-K | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
| Insider trade | 4 | 2026-05-21 |
The largest companies sharing Teladoc Health, Inc.'s SEC industry classification (services-offices & clinics of doctors of medicine).
Teladoc Health, Inc. (TDOC) has a market capitalization of $1.27 B as of 2026-06-10, ranking #2459 among US-listed companies.
Teladoc Health, Inc. reported revenue of $2.53B for fiscal year 2025, a decrease of 1.5% year over year.
In its latest fiscal year Teladoc Health, Inc. reported a net loss of $200.32M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.